CALA — Calithera Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$25.45m
Annual cashflow statement for Calithera Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -54.6 | -89.9 | -90.1 | -115 | -39.6 |
| Depreciation | |||||
| Non-Cash Items | 7.17 | 6.93 | 9.42 | 51.9 | 3.21 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -17.9 | 3.7 | -3.96 | -3.4 | -7.43 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -64.8 | -78.7 | -84.3 | -66.3 | -43.6 |
| Capital Expenditures | -0.214 | -0.007 | -0.061 | -0.147 | -0.133 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 53 | -10.8 | 89 | 8 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 52.8 | -10.8 | 89 | 7.85 | -0.133 |
| Financing Cash Flow Items | — | — | — | -0.173 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 14.6 | 98.9 | 42.1 | 10.7 | 9.65 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.58 | 9.38 | 46.7 | -47.8 | -34.1 |